1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Global Cancer Statistics, Cancer J, Clin WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of Non-Small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest (2007) 132: 234–242. doi: 10.1378/chest.07-1378 [3] Stanic, Paulus S, Timmerman R, Michalski RD, Barriger JM, Bezjak RB A, No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol Biol Phys (2014) 88: 1092–1099. doi:, Schipper X, Kidwell M, Lin K, Reddy J, Ren R Y, Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys (2014) 90: 603–611. doi: 10.1016/j.ijrobp.2014.05.055 [5] Ma L, Xiang J et al. Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: A meta-analysis. Thorac Cancer (2016) 7: 442–451. doi: 10.1111/1759-7714.12352.
2. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a retrospective analysis. Lancet Oncol (, Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol (2012) 7: 152. doi:, Hope IS, Guckenberger AJ, Kestin M, Werner-Wasik LL, Yan M D, A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol (2012) 7: 1382–1393. doi: 10.1097/JTO.0b013e318260e00d [9], Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Outcome in a prospective phase II trial of medically inoperable stageInon-small-cell lung cancer patients treated with stereotactic body radiotherapy. Clin Oncol (2009) 27: 3290–3296. doi: 10.1200/JCO.2008.21.5681 [10] Grills IS, Mangona, Welsh VS, Chmielewski R, Mcinerney G, Martin E et al. S, Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol (2010) 28: 928–935. doi: 10.1016/j.ijrobp.2009.07.155.
3. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy;Yang H;Front Oncol,2022
4. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques;Palma DA;Int J Radiat Oncol Biol Phys,2011
5. Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancer;Timmerman RD;Int J RadiatOncol,2014